Erratum to “CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma” [Eur Urol 2017;72:962–71]
Escudier, Bernard, Sharma, Padmanee, McDermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., CastellanoLangue:
english
Journal:
European Urology
DOI:
10.1016/j.eururo.2017.12.016
Date:
January, 2018
Fichier:
PDF, 719 KB
english, 2018
File converter
Plus de résultats de recherche
More benefits 
